Basic science for the clinician 35 -: CD1, invariant NKT (iNKT) cells, and γδ T-cells

被引:8
|
作者
Sigal, LH
机构
[1] Bristol Myers Squibb, Pharmaceut Res Inst, Princeton, NJ 08543 USA
[2] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Rheumatol & Connect Tissue Res, Dept Med, New Brunswick, NJ USA
[3] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, New Brunswick, NJ 08903 USA
[4] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet & Microbiol, New Brunswick, NJ 08903 USA
关键词
CD1; gamma delta T-cells; invariant NKT cell; phosphoantigens; lipid antigens;
D O I
10.1097/01.rhu.0000191149.21528.f7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
As noted in previous articles in this series, the very heterogeneous MHC class I and II molecules present peptide antigens to T-cells. However, there is another family of less heterogeneous MHC-related molecules. CD11 molecules present lipid antigens, oftentimes to 2 other distinct families of T-cells: gamma delta T-cells (named because they bear a T-cell antigen receptor consisting of a gamma chain and a delta chain rather than the a chain/beta chain heterodimer on most T-cells) and iNKT cells (T-cells that bear markers previously defined on natural killer cells). CD1 molecules and the gamma delta T-cells and iNKT cells to which they present antigens have fundamental responsibilities for immune surveillance over intracellular pathogens and serve other roles that place them at the boundary between innate and acquired immunity. The gamma delta T-cell has been implicated in the pathogenesis of many diseases, rheumatologic and otherwise, suggesting that better understanding of these cells, and of CD1 molecules, may help us explain the immunopathogenesis of some inflammatory diseases and how to craft more targeted therapies in many fields of medicine.
引用
收藏
页码:336 / 339
页数:4
相关论文
共 50 条
  • [1] CD1 and MR1 recognition by human γδ T cells
    Van Rhijn, Ildiko
    Le Nours, Jerome
    MOLECULAR IMMUNOLOGY, 2021, 133 : 95 - 100
  • [2] Donor-unrestricted T cells in the human CD1 system
    Huang, Shouxiong
    Moody, D. Branch
    IMMUNOGENETICS, 2016, 68 (08) : 577 - 596
  • [3] Donor-unrestricted T cells in the human CD1 system
    Shouxiong Huang
    D. Branch Moody
    Immunogenetics, 2016, 68 : 577 - 596
  • [4] CD1 and mycobacterial lipids activate human T cells
    Van Rhijn, Ildiko
    Moody, D. Branch
    IMMUNOLOGICAL REVIEWS, 2015, 264 (01) : 138 - 153
  • [5] Four pathways of CD1 antigen presentation to T cells
    Moody, D. Branch
    Cotton, Rachel N.
    CURRENT OPINION IN IMMUNOLOGY, 2017, 46 : 127 - 133
  • [6] Antibody responses to glycolipid-borne carbohydrates require CD4+ T cells but not CD1 or NKT cells (vol 89, pg 502, 2011)
    Christiansen, Dale
    Vaughan, Hilary A.
    Milland, Julie
    Dodge, Natalie
    Mouhtouris, Effie
    Smyth, Mark J.
    Godfrey, Dale I.
    Sandrin, Mauro S.
    IMMUNOLOGY AND CELL BIOLOGY, 2011, 89 (04) : 574 - 574
  • [7] The CD1 family: serving lipid antigens to T cells since the Mesozoic era
    Zajonc, Dirk M.
    IMMUNOGENETICS, 2016, 68 (08) : 561 - 576
  • [8] Activation of human T cells by CD1 and self-lipids
    de Jong, Annemieke
    IMMUNOLOGICAL REVIEWS, 2015, 267 (01) : 16 - 29
  • [9] Primary immunodeficiency associated with defects in CD1 and CD1-restricted T cells
    Zeissig, Sebastian
    Blumberg, Richard S.
    YEAR IN HUMAN AND MEDICAL GENETICS: INBORN ERRORS OF IMMUNITY III, 2012, 1250 : 14 - 24
  • [10] Invariant NKT cells and CD1d+ cells amass in human omentum and are depleted in patients with cancer and obesity
    Lynch, Lydia
    O'Shea, Donal
    Winter, Desmond C.
    Geoghegan, Justin
    Doherty, Derek G.
    O'Farrelly, Cliona
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (07) : 1893 - 1901